[15] [16] For weight management, FDA-approved agents include semaglutide 2.4 mg (Wegovy), tirzepatide (Zepbound), and liraglutide 3 mg (Saxenda), with weight reduction varying by medication (typically 5-15% with liraglutide, 15-20% with semaglutide, and up to 20-25% with tirzepatide)
If your BMI is 27 or higher, you may still be an ideal candidate if you manage at least one weight-related medical condition, such as high blood pressure, high cholesterol, or obstructive sleep apnea
Our COA reading guide walks through each section so researchers can verify batch-specific results before starting a study
Wong ND, Zhao Y, Patel R et al (2016) Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the atherosclerosis risk in communities study, multi-ethnic study of atherosclerosis, and jackson heart study